Literature DB >> 3928482

Pathologic pulmonary alterations in long-term human heart-lung transplantation.

S A Yousem, C M Burke, M E Billingham.   

Abstract

Twenty-one patients with end-stage pulmonary hypertension underwent combined allograft heart-lung transplantation after 1980. Almost 80 per cent of these patients survived beyond the immediate postoperative period, with the longest survival period more than 3 1/2 years at the time of this report. Five patients died in the perioperative or immediate postoperative period, and 11 returned to normal lives with essentially normal pulmonary function. In the remaining five allograft recipients recurrent respiratory infections and progressive obstructive airway disease developed, with superimposed restrictive deficits in three of them. Two open lung biopsies, two autopsies, and one retransplantation were performed in these recipients. Morphologically, these allograft recipients showed extensive bronchiolitis obliterans, interstitial and pleural fibrosis, and accelerated arterial and venous arteriosclerosis. Bronchiolitis obliterans may prove to be a significant complication of heart-lung transplantation.

Entities:  

Mesh:

Year:  1985        PMID: 3928482     DOI: 10.1016/s0046-8177(85)80130-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  23 in total

Review 1.  Graft-versus-host disease of the intestine.

Authors:  G J Cox; G B McDonald
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

3.  Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis.

Authors:  Ashok N Babu; Tomohiro Murakawa; Joshua M Thurman; Edmund J Miller; Peter M Henson; Martin R Zamora; Norbert F Voelkel; Mark R Nicolls
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 4.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  A pathologic analysis of the outcome following heart-lung transplantation: an autopsy study of 22 recipients.

Authors:  H Ishibashi-Ueda; G Chomette; A Delcourt; M Auriol; Y Le Charpentier; C Cabrol
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

6.  Rejection of combined heart-lung transplants in rats. Function and pathology.

Authors:  J Prop; H D Tazelaar; M E Billingham
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

7.  Immunologically mediated disease of the airways after pulmonary transplantation.

Authors:  B P Griffith; I L Paradis; A Zeevi; H Rabinowich; S A Yousem; R J Duquesnoy; J H Dauber; R L Hardesty
Journal:  Ann Surg       Date:  1988-09       Impact factor: 12.969

Review 8.  Chronic lung allograft dysfunction phenotypes and treatment.

Authors:  Stijn E Verleden; Robin Vos; Bart M Vanaudenaerde; Geert M Verleden
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 9.  The role of the immune system in lung transplantation: towards improved long-term results.

Authors:  Ramsey R Hachem
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 10.  Heart-lung and lung transplantation for cystic fibrosis.

Authors:  N Lewiston; V Starnes; J Theodore
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.